. – John Tchelingerian, PhD  (Chair), Dharminder Singh Chahal and Prof. Dr. Chris Bangma to form Supervisory Board Pan Cancer T B.V., a biotech company discovering and developing first-in-class T-cell receptor (TCR) T-cell therapy for hard-to-treat solid tumors, today announced […]